Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection (Q34937444)
scientific article published on May 1, 2003
Language:
(P31) (Q13442814)
(P304) 1700-1706
(P407) (Q1860)
(P433) 5
(P478) 47
(P577) Thursday, May 1, 2003
(P921) (Q188121)
(Q2425020)
(Q128406)
(Q725307)
(P953) https://europepmc.org/articles/pmc153305?pdf=render
https://europepmc.org/articles/PMC153305
https://europepmc.org/articles/PMC153305?pdf=render
https://doi.org/10.1128/aac.47.5.1700-1706.2003
https://journals.asm.org/doi/pdf/10.1128/AAC.47.5.1700-1706.2003
(P1104) 7
(P1433) (Q578004)
(P1476) "Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection" (language: en)
"Pharmacodynamics of Oritavancin (LY333328) in a Neutropenic-Mouse Thigh Model of Staphylococcus aureus Infection" (language: en)
(P2093) Kristina Campanale
Carole J. Boylan
Philip W. Iversen
Diane L. Phillips
Michael L. Zeckel
Thomas R. Parr
(P2860) (Q34347926)
(Q39477892)
(Q28362193)
(Q33981666)
(Q33594048)
(Q33593883)
(Q33979559)
(Q33979426)
(Q30326190)
(Q33976683)
(Q33976444)
(Q33698979)
(Q45113221)
(Q54133149)
(Q35138989)
(Q35138478)
(Q41522164)
(Q35136776)
(Q35136634)
(Q54297609)
(Q43587155)
(Q54039166)
(Q42878845)
(Q52569318)
(Q71236157)
(Q71821053)
(Q578004)
other details
description scientific article published on May 1, 2003

External Links